Biotechnology Innoveren Scientific’s (OTCMKTS: IVRN) 510(k) Submission Sparks A New Hope For Patients Living With Chronic Non-Healing Wounds – Innoveren Scientific (OTC:IVRN) Read more
Biotechnology Tharimmune’s Oral ‘Under The Cheek’ Candidate At Par With FDA-Approved Injectable With Potential For Chronic Liver Disease – Tharimmune (NASDAQ:THAR) Read more
Biotechnology New Hope For Patients With Chronic Autoimmune Conditions: Johnson & Johnson’s Investigational Drug Meets Primary Goal In Two Studies – Johnson & Johnson (NYSE:JNJ) Read more